AASMA RIAZ: Open Payments
NPI 1497981187 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 24 payments from 11 companies in 2025. Trend: 2023 $426 · 2024 $813 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| Next Science LLC | 2 | $88 |
| Novo Nordisk Inc | 4 | $86 |
| ABBVIE INC. | 3 | $67 |
| Amgen Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Lilly USA, LLC | 2 | $43 |
| Exact Sciences Corporation | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $17 |
Products named: Xperience, AIRSUPRA, Wegovy, TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, OTEZLA, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
